• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Phase Forward Chairman and Founder Paul Bleicher Honored By Boston Business Journal for Innovation in Health Care; Recognized for Revolutionizing Clinical Data Collection in the Biopharmaceutical Industry

Posted on: Thursday, 10 August 2006, 12:01 CDT

Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that Chairman and Founder Dr. Paul Bleicher has been named to the Boston Business Journal's Champions in Health Care list. The publication's third annual award honors the best and brightest professionals in the Bay State's world-class health care industry.

"The people and organizations we recognized this year illustrate once again our region's ability to innovate in an industry that is not only important to the local economy, but society as a whole," said Michael Olivieri, Boston Business Journal publisher.

Dr. Bleicher built Phase Forward around his vision of leveraging the Internet as a platform for clinical data collection and collaboration. He has become a well known expert and trusted advisor in the area of clinical data management and continues to help revolutionize the industry's data collection processes for tracking and monitoring product efficacy and safety. Phase Forward continues to be recognized for innovation and excellence, including the prestigious Bio-IT World Bio-IT 50 award, a list which profiles those companies that "have driven and continue to drive the future of biomedical research and drug discovery."

"I'm grateful for Paul's unwavering dedication to the health care industry as a whole, and to our ability to help our customers bring safe drugs to market more efficiently," said Phase Forward President and CEO Bob Weiler. "His commitment is a cornerstone of the electronic data capture revolution - the benefits of which our customers, and their consumers, will reap today and for many generations to come."

Winners will be recognized in the Champions in Health Care Special Supplement in the August 11 edition of the Boston Business Journal, and honored at a breakfast event Wednesday, September 20, 7:30-9:00 a.m. at the Westin Copley Place. The event will be keynoted by Timothy Murphy, Secretary of the Executive Office of Health and Human Services for the Commonwealth of Massachusetts. For more information, visit http://boston.bizjournals.com/boston/event/2549.

About Phase Forward

Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. The company offers proven solutions for electronic data capture (InForm(TM)), clinical data management (Clintrial(TM)), clinical trials signal detection (CTSD(TM)), strategic pharmacovigilance (WebVDME(TM) and Signal Management), adverse event reporting (Clintrace(TM)) and applied data standards (WebSDM(TM)). In addition, the company provides services in the areas of application implementation, hosting and validation, data integration, business process optimization, safety data management and industry standards. Phase Forward's products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 230 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, Food and Drug Administration, GlaxoSmithKline, Merck, U.K. Medicines and Healthcare Products Regulatory Agency, National Institutes of Health, Procter & Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute, Serono and Servier. Additional information about Phase Forward is available at www.phaseforward.com.

Source: Business Wire

More News in this Category